Ka Lok Lee

Chinese University of Hong Kong

Papers

1

Total Citations

2

H-Index

1

About

Ka Lok Lee is a pioneering urologic surgeon and researcher whose work sits at the intersection of minimally invasive surgery and oncology. His primary research focuses on robotic waterjet ablation—specifically Aquablation—for treating benign prostatic hyperplasia and localized prostate cancer. Lee’s major contribution is demonstrating that Aquablation not only relieves lower urinary tract symptoms in men with prostate cancer but does so without causing a significant surge in circulating tumor cells, a critical safety finding that challenges assumptions about surgical tumor dissemination. His 2025 prospective study on this topic has already garnered 2 citations, signaling early impact in a rapidly evolving field. Beyond this, Lee is known for integrating advanced imaging (mpMRI) with surgical planning, refining patient selection for tissue-preserving therapies. His work bridges the gap between functional urology and oncologic precision, offering men a treatment that addresses both cancer control and quality of life. As robotic waterjet technology gains traction, Lee’s research is shaping the evidence base for a new standard in prostate care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Waterjet Resection for Men With Prostate Cancer Suffering From Lower Urinary Tract Symptoms
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Chinese University of Hong Kong

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago